| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Chief Legal & People Officer | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
| G1 Therapeutics, Inc. | Chief Legal & People Officer | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GTHX | G1 Therapeutics, Inc. | Sep 18, 2024 | 4 | $0 | 4 | Sep 18, 2024 | Chief Legal & People Officer |
| GTHX | G1 Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Chief Legal & People Officer |
| GTHX | G1 Therapeutics, Inc. | May 23, 2024 | 1 | -$24.9K | 4 | May 24, 2024 | Chief Legal & People Officer |
| GTHX | G1 Therapeutics, Inc. | Mar 20, 2024 | 1 | $0 | 4 | Mar 22, 2024 | General Counsel |
| GTHX | G1 Therapeutics, Inc. | Jan 3, 2024 | 2 | $0 | 4 | Jan 8, 2024 | General Counsel |
| GTHX | G1 Therapeutics, Inc. | May 22, 2023 | 0 | $0 | 3 | May 24, 2023 | General Counsel |
| GTHX | G1 Therapeutics, Inc. | May 22, 2023 | 2 | $0 | 4 | May 24, 2023 | General Counsel |